During the Company issued notes payable, which matured through totaling as a portion of the consideration paid in connection with the Company’s various acquisitions. Interest rates ranged from to

 

During the Company issued notes payable totaling as a portion of the consideration paid in connection with the Company’s various acquisitions. Interest rates for both notes are with maturities through of There is outstanding note which will be paid upon execution of a final settlement and release agreement between the parties.

 

Maturities of notes payable are as follows as of

 

2018 (remainder)		$	100,000
Total		$	100,000

 

 

On the Company entered into a Credit and Security Agreement (the “Credit Agreement”) and signed a revolving credit note payable to the lender. Under the Credit Agreement, the Company is able to borrow up to an aggregate of under revolving loans. Interest on the unpaid outstanding principal amount of any revolving loans is at a rate equal to per annum, provided that the minimum amount of interest paid in the aggregate on all revolving loans granted over the term of the Credit Agreement is Interest is due and payable on the last day of each fiscal quarter in an amount determined by the Company, but less than The lender’s lending commitments under the Credit Agreement terminate in unless sooner terminated in accordance with the provisions of the Credit Agreement. The Credit Agreement is collateralized by the assets in the Company’s company-owned or managed clinics. The Company is using the credit facility for general working capital needs. As of the Company had drawn of the available under the Credit Agreement.